Liposarcoma News and Research

RSS
Common signaling pathway may control formation of tumor cells in fat, reveals Purdue study

Common signaling pathway may control formation of tumor cells in fat, reveals Purdue study

Experts to analyse latest advances in diagnosis, treatment of soft tissue sarcoma at PharmaMar seminar

Experts to analyse latest advances in diagnosis, treatment of soft tissue sarcoma at PharmaMar seminar

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

Study reports racial, ethnic differences in incidence of soft tissue sarcomas in young adults, adolescents

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

Affymetrix introduces new OncoScan FFPE Assay Kit

Affymetrix introduces new OncoScan FFPE Assay Kit

New research may help clinicians determine factors that increase risk of blood clots after surgery

New research may help clinicians determine factors that increase risk of blood clots after surgery

FAC PET identifies liposarcoma tumors that are sensitive to chemotherapy

FAC PET identifies liposarcoma tumors that are sensitive to chemotherapy

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC

Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC

Research on rare cancers

Research on rare cancers

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

Insuring your health: Health law requires continued coverage for patients in clinical trials

Insuring your health: Health law requires continued coverage for patients in clinical trials

First Edition: August 24, 2010

First Edition: August 24, 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.